Researchers found preoperative blood glucose levels were associated with hospital length of stay for patients undergoing laparoscopic nephrectomy for RCC.
Rate of disease-free survival at 24 months higher with pembrolizumab versus placebo following nephrectomy.
The approval was based on data from an open-label phase 2 study which evaluated the efficacy and safety of Welireg in patients with von Hippel-Lindau-associated renal cell carcinoma and other VHL-associated tumors.
The approval was based on data from the pivotal phase 3 CLEAR (Study 307)/KEYNOTE-581 trial.
Treatment-naïve patients had better outcomes than previously-treated patients.
Decisions of how to proceed when positive surgical margins are found after partial nephrectomy are left to the discretion of the surgeon.
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Ideal patient selection for a deferred cytoreductive nephrectomy should include an assessment of Memorial Sloan Kettering Cancer Center risk score, according to investigators.
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
A retrospective study identified factors that influenced overtreatment and undertreatment among patients with kidney cancer.
